
AstraZeneca Posts Solid Fourth Quarter, but Offers Weak 2013 Guidance
AstraZeneca reported strong fourth-quarter results that exceeded both our expectations and those of consensus, partly…
AstraZeneca reported strong fourth-quarter results that exceeded both our expectations and those of consensus, partly…